Cytogenetic and molecular changes in chronic B-cell leukemia.
Cytogenetic studies using B-cell mitogens indicate that approximately 50% of patients with chronic B-cell leukemia (CLL) have chromosome abnormalities. The most common abnormality is an additional chromosome 12, either as the sole abnormality or in conjunction with other abnormalities such as 14q+, 6q-, and 11q-. In two instances, the 14q+ is a result of a translocation from either chromosome 11, t(11;14), or chromosome 19, t(14;19). These two translocations led to the identification of the bcl-1 and bcl-3 genes located on chromosomes 11 and 19, respectively. Very few instances of oncogene activation have been described and it does not seem to be an important mechanism in the pathogenesis of CLL. Further cytogenetic and molecular studies may provide clues for the identification of the genes involved in CLL.
Crossen
P E
PE
Cytogenetic and Molecular Oncology Unit, Christchurch Hospital, New Zealand.
D001402:B-Lymphocytes / Q000276:immunology; D002869:Chromosome Aberrations; D015322:Gene Rearrangement, B-Lymphocyte; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics*; D008934:Mitogens; D009857:Oncogenes; D011379:Prognosis
D008934:Mitogens